Assessment of efficacy and safety of eslicarbazepine acetate for the treatment of trigeminal neuralgia

201845 citationsJournal Article

Authors

Álvaro Sánchez‐Larsen · Complejo Hospitalario Universitario de Albacete

D. Sopelana · Complejo Hospitalario Universitario de Albacete

I. Díaz-Maroto · Complejo Hospitalario Universitario de Albacete

A.B. Perona‐Moratalla · Complejo Hospitalario Universitario de Albacete

J. Gracia Gil · Complejo Hospitalario Universitario de Albacete

Susana García-Muñozguren · Grupo ACS (Spain)

Elena Palazón-García

Abstract

Eslicarbazepine acetate has shown to be an effective, safe and well-tolerated drug for TN. This is the first study that evaluated the efficacy of this drug on TN in humans.

Topics & Keywords

Trigeminal Neuralgia and Treatments Epilepsy research and treatment Pharmacological Effects and Toxicity Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: European Journal of Pain

Volume 22, Issue 6, pp. 1080-1087

DOI: 10.1002/ejp.1192

Field-Weighted Citation Impact: 4.65